Paris, France

Gabriel Rahmi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriel Rahmi: Innovator in Mucosal Healing

Introduction

Gabriel Rahmi is a notable inventor based in Paris, France. He has made significant contributions to the field of medical treatments, particularly in mucosal healing. His innovative work has led to the development of a unique composition aimed at treating fistulas in individuals.

Latest Patents

Gabriel Rahmi holds 1 patent for his invention titled "Compositions useful for mucosal healing." This patent describes a composition that includes at least one poloxamer compound, which is utilized in the treatment of fistulas. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Gabriel has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Cité. These affiliations have allowed him to collaborate with leading experts in his field and contribute to groundbreaking research.

Collaborations

Gabriel has had the opportunity to work alongside notable colleagues, including Olivier Clement and Christophe Cellier. Their combined expertise has likely enriched his research and development efforts.

Conclusion

Gabriel Rahmi's contributions to mucosal healing through his innovative patent reflect his dedication to improving medical treatments. His work continues to inspire advancements in healthcare and showcases the importance of innovation in addressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…